SYK · 8-K · 20261029PR000059
Guidance / Outlook
STRYKER CORP · 2026-10-29 · Importance 69 · Surprise 60 · In source text
On October 29, 2026, Stryker updated its full-year 2026 outlook to organic net sales growth of 6.5%–7.0% and adjusted diluted EPS of $14.80–$14.90. The sales outlook includes a modestly positive pricing impact. Foreign exchange is expected to have a slightly favorable effect on sales and adjusted diluted EPS if exchange rates remain near current levels. The CEO said the company expects solid Q4 performance and good momentum heading into 2027.
Key facts
- Stryker updated its full-year 2026 guidance to organic net sales growth of 6.5% to 7.0% and adjusted diluted EPS of $14.80 to $14.90. source
- Stryker expects solid performance in Q4 and good momentum heading into 2027. source
- Stryker's 2026 sales guidance includes a modestly positive pricing impact. source
- Foreign exchange is expected to have a slightly favorable impact on 2026 sales and adjusted diluted EPS if rates hold near current levels. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Stryker updated its full-year 2026 guidance to organic net sales growth of 6.5% to 7.0% and adjusted diluted EPS of $14.80 to $14.90. |
| net_income | unclear | committed | — | Stryker updated its full-year 2026 guidance to organic net sales growth of 6.5% to 7.0% and adjusted diluted EPS of $14.80 to $14.90. |